leisure time -WSS

leisure time

author：hotspot 2025-10-02 19:38:55 - browse：6239

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Hospital at home shows how to bring innovation to health care

WSS

Surgery pushed Ben Carson to fame

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Texas Medical Board asked to define abortion emergency exception

The CDC's new social media misinformation war

Adopting new red light myopia treatments may be short

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

entertainment

leisure time

Sign up for Morning Rounds

hotspot

How to save PrEP access — and even expand it

The Biogen Aduhelm mess could happen again

State Dept. review finds Biden bears some blame for Afghanistan failures

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

How to save PrEP access — and even expand it

PBMs are inflating the cost of generic drugs. They must be reined in

How to save PrEP access — and even expand it

Texas Medical Board asked to define abortion emergency exception

Trump demands the U.S. pay no more for drugs than other countries … again

FDA greenlights medical device to combat bladder issues

knowledge

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

National associations that represent hospice owe an apology

Intellia plays down concerns on accidental germline transmission

AstraZeneca stays mum on Medicare drug pricing negotiations

Health officials lay out plans to cope with respiratory virus season

Devoted Health’s losses in Medicare Advantage persist

Wikipedia

knowledge

entertainment

hotspot